Current Status of Mechanical Circulatory Support: A Systematic Review

Table 3

Adverse events rates (Events/100 patient-months) in first 12 months after implant for 1092 primary LVADs (INTERMACS: June 2006–March 2009, with permission from: Second INTERMACS annual report) [27].

Adverse event	Events	Rate
Device malfunction	113	1.98
Bleeding	944	16.52
Cardiac/vascular
Right heart failure	108	1.89
Myocardial infarction	4	0.07
Cardiac arrhythmia	439	7.68
Pericardial drainage	86	1.50
Hypertensiona	132	2.31
Arterial non-CNS thrombosis	20	0.35
Venous thrombotic event	83	1.45
Hemolysis	31	0.54
Infection	998	17.46
Neurologic dysfunction	164	2.87
Renal dysfunction	142	2.48
Hepatic dysfunction	52	0.91
Respiratory failure	257	4.50
Wound dehiscence	27	0.47
Psychiatric episode	112	1.96
Total “burden”	3712	64.96

CNS: central nervous system;
INTERMACS: Interagency registry for mechanical circulatory support;
LVAD: left ventricular assist device.